AKT1 and Alzheimer disease: It was reported to exhibit neuroprotective activities, notably against AD, through a range of mechanisms including antioxidant defense, apoptosis regulation, and modulation of amyloid-beta levels via the PI3K/Akt/mTOR pathway.